| Dr Glenn Leonel Konsky, DO | |
|
1417 8th Ave, Bethlehem, PA 18018 | |
| (484) 526-5210 | |
| Not Available |
| Full Name | Dr Glenn Leonel Konsky |
|---|---|
| Gender | Male |
| Speciality | Neurology |
| Experience | 11 Years |
| Location | 1417 8th Ave, Bethlehem, Pennsylvania |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1255674248 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 2084V0102X | Psychiatry & Neurology - Vascular Neurology | OS018703 (Pennsylvania) | Secondary |
| 2084N0400X | Psychiatry & Neurology - Neurology | OS018703 (Pennsylvania) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| St Luke's Hospital Bethlehem | Bethlehem, PA | Hospital |
| St Luke's Hospital - Anderson Campus | Easton, PA | Hospital |
| St Luke's Hospital - Monroe Campus | Stroudsburg, PA | Hospital |
| St Lukes Quakertown Hospital | Quakertown, PA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| St Luke's Physician Group Inc | 6709798333 | 1739 |
| Gslpg, Inc | 7810226875 | 227 |
| St Lukes Warren Physician Group Pc | 9739093675 | 314 |
News Archive
Scientists from The Scripps Research Institute have uncovered new evidence that challenges the current theory about a process key to the way modern drugs are designed and how they work in the human body.
Led by researchers at Lawson Health Research Institute, a multi-centre registry trial is testing the use of a new imaging tracer, called a PSMA tracer, for early detection of recurrent prostate cancer. The registry gives patients access to a new type of imaging and will assess the impact on patient care.
The UK's flagship event for health and safety is on course for a remarkable year as the event is nearing a sell out with more than five months to go. Currently, more than 300 companies will gather from 17-19 June at the London ExCeL for the Safety & Health Expo, part of UBM Live's Protection & Management Series.
As potential next-generation therapeutics and research tools, few life sciences technologies hold more promise than genome-editing proteins – molecules that can be programmed to alter specific genes in order to treat or even cure genetic diseases.
› Verified 3 days ago
| Entity Name | St Lukes Physician Group Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1700984622 PECOS PAC ID: 6709798333 Enrollment ID: O20040226000062 |
News Archive
Scientists from The Scripps Research Institute have uncovered new evidence that challenges the current theory about a process key to the way modern drugs are designed and how they work in the human body.
Led by researchers at Lawson Health Research Institute, a multi-centre registry trial is testing the use of a new imaging tracer, called a PSMA tracer, for early detection of recurrent prostate cancer. The registry gives patients access to a new type of imaging and will assess the impact on patient care.
The UK's flagship event for health and safety is on course for a remarkable year as the event is nearing a sell out with more than five months to go. Currently, more than 300 companies will gather from 17-19 June at the London ExCeL for the Safety & Health Expo, part of UBM Live's Protection & Management Series.
As potential next-generation therapeutics and research tools, few life sciences technologies hold more promise than genome-editing proteins – molecules that can be programmed to alter specific genes in order to treat or even cure genetic diseases.
› Verified 3 days ago
| Entity Name | Gslpg, Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1366006702 PECOS PAC ID: 7810226875 Enrollment ID: O20190917001763 |
News Archive
Scientists from The Scripps Research Institute have uncovered new evidence that challenges the current theory about a process key to the way modern drugs are designed and how they work in the human body.
Led by researchers at Lawson Health Research Institute, a multi-centre registry trial is testing the use of a new imaging tracer, called a PSMA tracer, for early detection of recurrent prostate cancer. The registry gives patients access to a new type of imaging and will assess the impact on patient care.
The UK's flagship event for health and safety is on course for a remarkable year as the event is nearing a sell out with more than five months to go. Currently, more than 300 companies will gather from 17-19 June at the London ExCeL for the Safety & Health Expo, part of UBM Live's Protection & Management Series.
As potential next-generation therapeutics and research tools, few life sciences technologies hold more promise than genome-editing proteins – molecules that can be programmed to alter specific genes in order to treat or even cure genetic diseases.
› Verified 3 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Glenn Leonel Konsky, DO 1417 8th Ave, Bethlehem, PA 18018-2256 Ph: (484) 526-5210 | Dr Glenn Leonel Konsky, DO 1417 8th Ave, Bethlehem, PA 18018 Ph: (484) 526-5210 |
News Archive
Scientists from The Scripps Research Institute have uncovered new evidence that challenges the current theory about a process key to the way modern drugs are designed and how they work in the human body.
Led by researchers at Lawson Health Research Institute, a multi-centre registry trial is testing the use of a new imaging tracer, called a PSMA tracer, for early detection of recurrent prostate cancer. The registry gives patients access to a new type of imaging and will assess the impact on patient care.
The UK's flagship event for health and safety is on course for a remarkable year as the event is nearing a sell out with more than five months to go. Currently, more than 300 companies will gather from 17-19 June at the London ExCeL for the Safety & Health Expo, part of UBM Live's Protection & Management Series.
As potential next-generation therapeutics and research tools, few life sciences technologies hold more promise than genome-editing proteins – molecules that can be programmed to alter specific genes in order to treat or even cure genetic diseases.
› Verified 3 days ago
Edgar M Vizcaino, M.D. Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 865 E 4th St, Bethlehem, PA 18015 Phone: 484-221-9136 Fax: 484-221-9130 | |
Dr. Sandra Wandji Veigne, M.D Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 801 Ostrum St, Bethlehem, PA 18015 Phone: 484-822-5700 | |
Dr. Jonathan P. Hosey, M.D. Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 1417 8th Ave, Bethlehem, PA 18018 Phone: 484-526-5210 Fax: 484-526-5237 | |
Itay Keshet, MD Psychiatry & Neurology Medicare: Medicare Enrolled Practice Location: 2545 Schoenersville Rd, Bethlehem, PA 18017 Phone: 484-884-2888 Fax: 484-884-2885 | |
Brian Hanrahan, M.D. Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 1417 8th Ave, Bethlehem, PA 18018 Phone: 484-526-5210 | |
Laurence P Karper, MD Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 2545 Schoenersville Rd, 5th Floor Lvh-m South, Bethlehem, PA 18017 Phone: 484-884-6503 Fax: 484-884-6504 | |
Rekha Srinivasan, MD Psychiatry & Neurology Medicare: Medicare Enrolled Practice Location: 2710 Schoenersville Rd, Bethlehem, PA 18017 Phone: 610-297-7500 Fax: 610-297-7533 |